Wu Hongliu studied organic chemistry for his PhD degree at America's Duke University, and completed his NIH fellow research with California based Scripps Research Institute.

But even several biopharmaceutical breakthroughs couldn't keep the young scientist from his home country.

Nearly a decade after graduation, Wu returned to China, where he founded Beijing Kaining Bioscience Co.